idefirix
hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - imunosupresoare - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.
mediu rajhans
societatea nationala "institutul pasteur" sa -
yomogi 250 mg capsule
ardeypharm gmbh - saccharomyces boulardii - capsule - 250 mg
glyclada 30 mg comprimate cu eliberare prelungită
krka d.d., novo mesto - gliclazidum - comprimate cu eliberare prelungită - 30 mg
hepatitis b vaccine suspensie injectabila 20 mcg/ml
serum institute of india pvt.ltd - vaccin hepatitic b - suspensie injectabila - 20 mcg/ml
hepatitis b vaccine suspensie injectabila 20 mcg/ml
serum institute of india pvt.ltd - vaccin hepatitic b - suspensie injectabila - 20 mcg/ml
hepatitis b vaccine suspensie injectabila 20 mcg/ml
serum institute of india pvt.ltd - vaccin hepatitic b - suspensie injectabila - 20 mcg/ml
hepatitis b vaccine suspensie injectabila 10 mcg/0,5 ml
serum institute of india pvt.ltd - vaccin hepatitic b - suspensie injectabila - 10 mcg/0,5 ml
hepatitis b vaccine suspensie injectabila 10 mcg/0,5 ml
serum institute of india pvt.ltd - vaccin hepatitic b - suspensie injectabila - 10 mcg/0,5 ml
hepatitis b vaccine suspensie injectabila 10 mg/0,5 ml
serum institute of india pvt.ltd - vaccin hepatitic b - suspensie injectabila - 10 mg/0,5 ml